Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If
a full report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02460978” into
the search box and click “Search”.
• www.clinicaltrialsregister.eu. Once you are on the website, click “Home and
Search”, then type “2014-004599-49” in the search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D1695C00007” into the search box and click “Find a Study”.
Full Trial Title: A Multicentre, Randomised, Double-Blind, Placebo-controlled,
Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin
as an Add-on to Insulin Therapy in Subjects with Type 1 Diabetes Mellitus
AstraZeneca Protocol Number: D1695C00007
AstraZeneca sponsored this study and has its headquarters at
1800 Concord Pike in Wilmington, Delaware.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part
in clinical research around the world. They help researchers answer important
health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 2.19 2019_06_13 12